| Amgen (AMGN) |
United States |
$147.238B |
15.40 |
| Bristol Myers Squibb (BMY) |
United States |
$146.233B |
10.16 |
| CSL (CSLLY) |
Australia |
$95.302B |
0.00 |
| Gilead Sciences (GILD) |
United States |
$84.193B |
9.43 |
| Moderna (MRNA) |
United States |
$68.414B |
0.00 |
| Illumina (ILMN) |
United States |
$58.214B |
88.67 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$56.783B |
24.24 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$53.845B |
17.60 |
| Biogen (BIIB) |
United States |
$41.178B |
8.24 |
| BioNTech SE (BNTX) |
Germany |
$36.600B |
947.13 |
| Alexion Pharmaceuticals (ALXN) |
United States |
$36.159B |
14.01 |
| BeiGene (BGNE) |
Cayman Islands |
$28.018B |
0.00 |
| Seagen (SGEN) |
United States |
$26.380B |
45.19 |
| Genmab (GMAB) |
Denmark |
$23.106B |
32.32 |
| Exact Sciences (EXAS) |
United States |
$21.989B |
0.00 |
| Genmab (GNMSF) |
Denmark |
$21.839B |
5.18 |
| Horizon Therapeutics Public (HZNP) |
Ireland |
$20.899B |
23.98 |
| SINO PHARMACEUT (SBMFF) |
Hong Kong, SAR China |
$18.882B |
0.00 |
| Incyte (INCY) |
United States |
$18.177B |
0.00 |
| Bio-Rad Laboratories (BIO.B) |
United States |
$17.932B |
57.06 |
| Novavax (NVAX) |
United States |
$16.792B |
0.00 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$16.293B |
0.00 |
| Bio-Techne Corp (TECH) |
United States |
$16.239B |
93.01 |
| Guardant Health (GH) |
United States |
$15.918B |
0.00 |
| Zai Lab (ZLAB) |
China |
$14.555B |
0.00 |
| ARGENX SE-ADR (ARGX) |
Netherlands |
$14.454B |
0.00 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$14.437B |
115.07 |
| QIAGEN (QGEN) |
Netherlands |
$12.026B |
24.53 |
| Repligen (RGEN) |
United States |
$11.683B |
128.49 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$8.943B |
0.00 |
| AbCellera Biologics (ABCL) |
|
$8.036B |
0.00 |
| Mirati Therapeutics (MRTX) |
United States |
$8.010B |
0.00 |
| Fate Therapeutics (FATE) |
United States |
$7.612B |
0.00 |
| Acceleron Pharma (XLRN) |
United States |
$7.390B |
0.00 |
| Exelixis (EXEL) |
United States |
$7.360B |
67.40 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$7.279B |
0.00 |
| Halozyme Therapeutics (HALO) |
United States |
$6.651B |
51.57 |
| Twist Bioscience (TWST) |
United States |
$6.579B |
0.00 |
| Ascendis Pharma (ASND) |
Denmark |
$6.555B |
0.00 |
| Denali Therapeutics (DNLI) |
United States |
$6.534B |
207.73 |
| Vir Biotechnology (VIR) |
United States |
$5.936B |
0.00 |
| Adaptive Biotechnologies (ADPT) |
United States |
$5.851B |
0.00 |
| NeoGenomics (NEO) |
United States |
$5.775B |
704.86 |
| Sarepta Therapeutics (SRPT) |
United States |
$5.702B |
0.00 |
| Blueprint Medicines (BPMC) |
United States |
$5.518B |
18.17 |
| Galapagos (GLPG) |
Belgium |
$5.185B |
0.00 |
| SWEDISH ORP BIO (BIOVF) |
Sweden |
$5.040B |
15.85 |
| Intellia Therapeutics (NTLA) |
United States |
$4.771B |
0.00 |
| Biohaven Pharmaceutical Holding (BHVN) |
United States |
$4.616B |
0.00 |
| Beam Therapeutics (BEAM) |
United States |
$4.541B |
0.00 |
| Certara (CERT) |
United States |
$4.293B |
0.00 |
| Emergent Biosolutions (EBS) |
United States |
$4.160B |
9.89 |
| I-Mab (IMAB) |
China |
$4.101B |
0.00 |
| Arena Pharmaceuticals (ARNA) |
United States |
$3.976B |
0.00 |
| Atea Pharmaceuticals (AVIR) |
United States |
$3.718B |
0.00 |
| Apellis Pharmaceuticals (APLS) |
United States |
$3.663B |
0.00 |
| Legend Biotech (LEGN) |
United States |
$3.458B |
0.00 |
| SpringWorks Therapeutics (SWTX) |
United States |
$3.429B |
0.00 |
| Insmed (INSM) |
United States |
$3.415B |
0.00 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$3.385B |
0.00 |
| Reata Pharmaceuticals (RETA) |
United States |
$3.290B |
0.00 |
| Berkeley Lights (BLI) |
United States |
$3.177B |
0.00 |
| Alkermes (ALKS) |
Ireland |
$3.164B |
0.00 |
| Arvinas (ARVN) |
United States |
$3.162B |
0.00 |
| Seer (SEER) |
|
$3.097B |
0.00 |
| BAVARIAN NORDIC (BVNRY) |
Denmark |
$3.022B |
42.81 |
| MorphoSys AG (MOR) |
Germany |
$2.980B |
45.30 |
| Deciphera Pharmaceuticals (DCPH) |
United States |
$2.708B |
0.00 |
| Vericel (VCEL) |
United States |
$2.702B |
1172.40 |
| Amicus Therapeutics (FOLD) |
United States |
$2.627B |
0.00 |
| Global Blood Therapeutics (GBT) |
United States |
$2.537B |
0.00 |
| Intra-Cellular Therapies (ITCI) |
United States |
$2.526B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$2.496B |
47.24 |
| ALX Oncology Holdings (ALXO) |
United States |
$2.437B |
0.00 |
| Arcus Biosciences (RCUS) |
United States |
$2.348B |
0.00 |
| Editas Medicine (EDIT) |
United States |
$2.335B |
0.00 |
| Dicerna Pharmaceuticals (DRNA) |
United States |
$2.210B |
0.00 |
| Sorrento Therapeutics (SRNE) |
United States |
$2.140B |
0.00 |
| PHARMA MAR SA (PHMMF) |
Spain |
$2.074B |
0.00 |
| Myriad Genetics (MYGN) |
United States |
$2.054B |
0.00 |
| NGM Biopharmaceuticals (NGM) |
United States |
$2.006B |
0.00 |
| Amarin (AMRN) |
Ireland |
$1.975B |
0.00 |
| Revance Therapeutics (RVNC) |
United States |
$1.943B |
0.00 |
| Bluebird Bio (BLUE) |
United States |
$1.899B |
0.00 |
| Seres Therapeutics (MCRB) |
United States |
$1.898B |
0.00 |
| Heska (HSKA) |
United States |
$1.870B |
0.00 |
| Inovio Pharmaceuticals (INO) |
United States |
$1.821B |
0.00 |
| Morphic Holding (MORF) |
United States |
$1.787B |
0.00 |
| Five Prime Therapeutics (FPRX) |
United States |
$1.770B |
0.00 |
| Cytokinetics (CYTK) |
United States |
$1.767B |
0.00 |
| Genetron Holdings (GTH) |
China |
$1.763B |
0.00 |
| Kymera Therapeutics (KYMR) |
United States |
$1.732B |
0.00 |
| PureTech Health (PRTC) |
United States |
$1.653B |
0.00 |
| Sangamo Therapeutics (SGMO) |
United States |
$1.650B |
0.00 |
| Immunocore Holdings (IMCR) |
United Kingdom |
$1.650B |
0.00 |
| Castle Biosciences (CSTL) |
United States |
$1.636B |
0.00 |
| BioAtla (BCAB) |
United States |
$1.607B |
0.00 |
| ADC Therapeutics SA (ADCT) |
Switzerland |
$1.604B |
0.00 |
| Harmony Biosciences Holdings (HRMY) |
United States |
$1.602B |
0.00 |
| Bionano Genomics (BNGO) |
United States |
$1.577B |
0.00 |
| Precigen (PGEN) |
United States |
$1.540B |
0.00 |
| UniQure (QURE) |
Netherlands |
$1.533B |
0.00 |
| Codexis (CDXS) |
United States |
$1.520B |
0.00 |
| Travere Therapeutics (TVTX) |
United States |
$1.508B |
0.00 |
| REGENXBIO (RGNX) |
United States |
$1.467B |
0.00 |
| Cara Therapeutics (CARA) |
United States |
$1.422B |
356.38 |
| Alector (ALEC) |
United States |
$1.417B |
0.00 |
| Zealand Pharma (ZEAL) |
Denmark |
$1.413B |
0.00 |
| C4 Therapeutics (CCCC) |
United States |
$1.404B |
0.00 |
| Zymeworks (ZYME) |
Canada |
$1.402B |
0.00 |
| Keros Therapeutics (KROS) |
United States |
$1.319B |
0.00 |
| MiMedx (MDXG) |
United States |
$1.297B |
0.00 |
| Nurix Therapeutics (NRIX) |
United States |
$1.287B |
0.00 |
| Shattuck Labs (STTK) |
United States |
$1.254B |
0.00 |
| Repare Therapeutics (RPTX) |
Canada |
$1.246B |
0.00 |
| Dynavax Technologies (DVAX) |
United States |
$1.245B |
0.00 |
| Forma Therapeutics Holdings (FMTX) |
United States |
$1.215B |
0.00 |
| Zealand Pharma (ZLDPF) |
Denmark |
$1.167B |
0.00 |
| Protagonist Therapeutics (PTGX) |
United States |
$1.167B |
0.00 |
| Avid Bioservices (CDMO) |
United States |
$1.165B |
0.00 |
| Mesoblast (MESO) |
Australia |
$1.160B |
0.00 |
| Mersana Therapeutics (MRSN) |
United States |
$1.150B |
0.00 |
| Nkarta (NKTX) |
United States |
$1.143B |
0.00 |
| Y-mAbs Therapeutics (YMAB) |
United States |
$1.141B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
United States |
$1.130B |
0.00 |
| OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$1.123B |
0.00 |
| Ocugen (OCGN) |
United States |
$1.087B |
0.00 |
| Pliant Therapeutics (PLRX) |
United States |
$1.070B |
0.00 |
| Arcturus Therapeutics Holdings (ARCT) |
United States |
$1.060B |
0.00 |
| Scholar Rock Holding (SRRK) |
United States |
$1.054B |
0.00 |
| Coherus BioSciences (CHRS) |
United States |
$1.052B |
8.51 |
| Curis (CRIS) |
United States |
$1.052B |
0.00 |
| MannKind (MNKD) |
United States |
$1.041B |
0.00 |
| Prothena (PRTA) |
Ireland |
$0.994B |
0.00 |
| G1 THERAPEUTICS (GTHX) |
United States |
$0.986B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$0.985B |
0.00 |
| Prometheus Biosciences (RXDX) |
United States |
$0.968B |
0.00 |
| Celldex Therapeutics (CLDX) |
United States |
$0.933B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$0.918B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.915B |
38.77 |
| Adverum Biotechnologies (ADVM) |
United States |
$0.866B |
0.00 |
| Merus (MRUS) |
Netherlands |
$0.859B |
0.00 |
| Affimed (AFMD) |
Germany |
$0.840B |
0.00 |
| Pharming Group (PHAR) |
Netherlands |
$0.835B |
0.00 |
| Cellectis S.A (CLLS) |
France |
$0.830B |
0.00 |
| Epizyme (EPZM) |
United States |
$0.824B |
0.00 |
| Bolt Biotherapeutics (BOLT) |
United States |
$0.812B |
0.00 |
| KaloBios Pharmaceuticals (HGEN) |
United States |
$0.788B |
0.00 |
| Pharming Group (PHGUF) |
Netherlands |
$0.782B |
20.83 |
| Avidity Biosciences (RNA) |
United States |
$0.780B |
0.00 |
| Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.766B |
0.00 |
| Orchard Therapeutics (ORTX) |
United Kingdom |
$0.745B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$0.729B |
0.00 |
| ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.717B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$0.703B |
0.00 |
| VBI Vaccines (VBIV) |
United States |
$0.688B |
0.00 |
| Inhibrx (INBX) |
United States |
$0.681B |
0.00 |
| Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.680B |
0.00 |
| Kadmon Holdings (KDMN) |
United States |
$0.674B |
0.00 |
| Intercept Pharmaceuticals (ICPT) |
United States |
$0.670B |
0.00 |
| DBV Technologies S.A (DBVT) |
France |
$0.664B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.640B |
35.94 |
| Clovis Oncology (CLVS) |
United States |
$0.625B |
0.00 |
| MeiraGTx Holdings (MGTX) |
United States |
$0.623B |
0.00 |
| ALBIREO PHARMA (ALBO) |
United States |
$0.623B |
0.00 |
| Starpharma Holdings (SPHRY) |
Australia |
$0.601B |
0.00 |
| IDEAYA Biosciences (IDYA) |
United States |
$0.600B |
0.00 |
| AnaptysBio (ANAB) |
United States |
$0.594B |
0.00 |
| Compugen (CGEN) |
Israel |
$0.586B |
0.00 |
| Adagene (ADAG) |
|
$0.580B |
0.00 |
| Anika Therapeutics (ANIK) |
United States |
$0.576B |
191.48 |
| ChromaDex (CDXC) |
United States |
$0.547B |
0.00 |
| Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.539B |
0.00 |
| Agenus (AGEN) |
United States |
$0.536B |
0.00 |
| RAPT THERAPTICS (RAPT) |
United States |
$0.519B |
0.00 |
| Inventiva S.A (IVA) |
France |
$0.515B |
0.00 |
| Neoleukin Therapeutics (NLTX) |
United States |
$0.506B |
0.00 |
| Precision BioSciences (DTIL) |
United States |
$0.501B |
0.00 |
| Forte Biosciences (FBRX) |
United States |
$0.497B |
0.00 |
| XBiotech (XBIT) |
United States |
$0.495B |
0.00 |
| Amryt Pharma (AMYT) |
United Kingdom |
$0.493B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.487B |
0.00 |
| Geron (GERN) |
United States |
$0.468B |
0.00 |
| Verastem (VSTM) |
United States |
$0.460B |
0.00 |
| Kala Pharmaceuticals (KALA) |
United States |
$0.460B |
0.00 |
| Selecta Biosciences (SELB) |
United States |
$0.435B |
0.00 |
| Gritstone Oncology (GRTS) |
United States |
$0.423B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
United States |
$0.423B |
11.79 |
| XOMA (XOMA) |
United States |
$0.422B |
93.75 |
| AquaBounty Technologies (AQB) |
United States |
$0.415B |
0.00 |
| Angion Biomedica (ANGN) |
United States |
$0.415B |
0.00 |
| Seelos Therapeutics (SEEL) |
United States |
$0.412B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$0.405B |
0.00 |
| Opthea (OPT) |
Australia |
$0.395B |
0.00 |
| Aeglea BioTherapeutics (AGLE) |
United States |
$0.392B |
0.00 |
| Cue Biopharma (CUE) |
United States |
$0.391B |
0.00 |
| Fortress Biotech (FBIO) |
United States |
$0.391B |
0.00 |
| SESEN BIO, INC (SESN) |
United States |
$0.390B |
0.00 |
| Adicet Bio (ACET) |
United States |
$0.389B |
0.00 |
| UROGEN PHARMA (URGN) |
United States |
$0.383B |
0.00 |
| Syros Pharmaceuticals (SYRS) |
United States |
$0.383B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.381B |
0.00 |
| Fulcrum Therapeutics (FULC) |
United States |
$0.377B |
0.00 |
| Paratek Pharmaceuticals (PRTK) |
United States |
$0.376B |
0.00 |
| Nabriva Therapeutics AG (NBRV) |
Ireland |
$0.375B |
0.00 |
| Athenex (ATNX) |
United States |
$0.371B |
0.00 |
| Athersys (ATHX) |
United States |
$0.364B |
0.00 |
| Bellus Health (BLU) |
Canada |
$0.359B |
0.00 |
| SQZ Biotechnologies (SQZ) |
United States |
$0.354B |
0.00 |
| Innate Pharma S.A (IPHA) |
France |
$0.348B |
0.00 |
| BioDelivery Sciences (BDSI) |
United States |
$0.345B |
13.68 |
| Theratechnologies (THTX) |
Canada |
$0.338B |
0.00 |
| Frequency Therapeutics (FREQ) |
United States |
$0.328B |
0.00 |
| HOOKIPA Pharma (HOOK) |
United States |
$0.326B |
0.00 |
| Cogent Biosciences (COGT) |
United States |
$0.316B |
0.00 |
| Oncobiologics (OTLK) |
United States |
$0.316B |
0.00 |
| Cardiff Oncology (CRDF) |
United States |
$0.311B |
0.00 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.307B |
0.00 |
| ProQR Therapeutics (PRQR) |
Netherlands |
$0.301B |
0.00 |
| Trevena (TRVN) |
United States |
$0.300B |
0.00 |
| CorMedix Inc (CRMD) |
United States |
$0.297B |
0.00 |
| Arbutus Biopharma (ABUS) |
United States |
$0.296B |
0.00 |
| Codiak BioSciences (CDAK) |
United States |
$0.283B |
0.00 |
| PDL BioPharma (PDLI) |
United States |
$0.283B |
0.00 |
| Autolus Therapeutics (AUTL) |
United Kingdom |
$0.277B |
0.00 |
| Kaleido Biosciences (KLDO) |
|
$0.276B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.275B |
15.82 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.269B |
0.00 |
| NextCure (NXTC) |
United States |
$0.260B |
0.00 |
| OVID THERAPEUTC (OVID) |
United States |
$0.249B |
0.00 |
| Cerecor (CERC) |
United States |
$0.224B |
0.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.219B |
0.00 |
| Checkpoint Therapeutics (CKPT) |
United States |
$0.214B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.213B |
0.00 |
| OSMOTICA PHARM (OSMT) |
United States |
$0.205B |
0.00 |
| INmune Bio (INMB) |
United States |
$0.203B |
0.00 |
| Kindred Biosciences (KIN) |
United States |
$0.201B |
0.00 |
| ADMA Biologics Inc (ADMA) |
United States |
$0.200B |
0.00 |
| Eton Pharmaceuticals (ETON) |
United States |
$0.197B |
0.00 |
| TELA Bio (TELA) |
United States |
$0.196B |
0.00 |
| POXEL SA FRANCE (PXXLF) |
France |
$0.193B |
0.00 |
| LogicBio Therapeutics (LOGC) |
United States |
$0.188B |
0.00 |
| GENFIT S.A (GNFT) |
France |
$0.181B |
0.00 |
| Aptinyx (APTX) |
United States |
$0.179B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
United States |
$0.178B |
0.00 |
| Nicox SA (NICXF) |
France |
$0.172B |
0.00 |
| Voyager Therapeutics (VYGR) |
United States |
$0.172B |
4.80 |
| Applied Genetic Technologies (AGTC) |
United States |
$0.171B |
0.00 |
| Chiasma (CHMA) |
United States |
$0.169B |
0.00 |
| AVEO Pharmaceuticals (AVEO) |
United States |
$0.168B |
0.00 |
| Strongbridge Biopharma (SBBP) |
United States |
$0.164B |
0.00 |
| Antibe Therapeutics (ATBPF) |
Canada |
$0.163B |
0.00 |
| ObsEva SA (OBSV) |
Switzerland |
$0.162B |
0.00 |
| Enzo Biochem (ENZ) |
United States |
$0.161B |
0.00 |
| Clearside Biomedical (CLSD) |
United States |
$0.158B |
0.00 |
| Exicure (XCUR) |
United States |
$0.158B |
0.00 |
| X4 Pharmaceuticals (XFOR) |
United States |
$0.157B |
0.00 |
| Biofrontera AG (BFRA) |
Germany |
$0.152B |
0.00 |
| Catalyst Biosciences (CBIO) |
United States |
$0.149B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.148B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.148B |
0.00 |
| Erytech Pharma SA (ERYP) |
France |
$0.146B |
0.00 |
| Dyadic (DYAI) |
United States |
$0.138B |
0.00 |
| Pluristem Therapeutics (PSTI) |
Israel |
$0.138B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.135B |
0.00 |
| Evofem Biosciences (EVFM) |
United States |
$0.130B |
0.00 |
| Eyenovia (EYEN) |
United States |
$0.129B |
0.00 |
| Pieris Pharmaceuticals (PIRS) |
United States |
$0.127B |
0.00 |
| Orgenesis (ORGS) |
United States |
$0.125B |
257.00 |
| TRACON Pharmaceuticals (TCON) |
United States |
$0.125B |
0.00 |
| Liminal BioSciences (LMNL) |
Canada |
$0.124B |
0.00 |
| Liquidia Technologies (LQDA) |
United States |
$0.120B |
0.00 |
| Aytu BioPharma (AYTU) |
United States |
$0.116B |
0.00 |
| ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.114B |
0.00 |
| Galena Biopharma (SLS) |
United States |
$0.114B |
0.00 |
| Aptevo Therapeutics (APVO) |
United States |
$0.113B |
0.00 |
| Evogene (EVGN) |
Israel |
$0.113B |
0.00 |
| Beyond Air (XAIR) |
United States |
$0.112B |
0.00 |
| Zosano Pharma (ZSAN) |
United States |
$0.108B |
0.00 |
| Ecology Coatings (ABVC) |
United States |
$0.107B |
0.00 |
| Novogen (KZIA) |
Australia |
$0.107B |
0.00 |
| Cidara Therapeutics (CDTX) |
United States |
$0.103B |
0.00 |
| ARAVIVE, INC (ARAV) |
United States |
$0.102B |
0.00 |
| Lumos Pharma (LUMO) |
United States |
$0.101B |
0.00 |
| Leap Therapeutics (LPTX) |
United States |
$0.098B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.097B |
0.00 |
| PHASEBIO PHARMA (PHAS) |
United States |
$0.094B |
0.00 |
| F-star Therapeutics (FSTX) |
United Kingdom |
$0.092B |
0.00 |
| Cyclerion Therapeutics (CYCN) |
United States |
$0.088B |
0.00 |
| Cocrystal Pharma (COCP) |
United States |
$0.086B |
0.00 |
| Cleveland BioLabs (CBLI) |
United States |
$0.082B |
0.00 |
| CollPlant Biotechnologies (CLGN) |
Israel |
$0.082B |
0.00 |
| Vascular Biogenics (VBLT) |
Israel |
$0.081B |
0.00 |
| Celsion (CLSN) |
United States |
$0.080B |
0.00 |
| AIkido Pharma (AIKI) |
United States |
$0.079B |
0.00 |
| CytRx (CYTR) |
United States |
$0.078B |
0.00 |
| Adocia (ADOCY) |
France |
$0.077B |
0.00 |
| Vaccinex (VCNX) |
United States |
$0.069B |
0.00 |
| Edesa Biotech (EDSA) |
Canada |
$0.068B |
0.00 |
| Purple Biotech (PPBT) |
Israel |
$0.068B |
0.00 |
| BioCardia (BCDA) |
United States |
$0.065B |
0.00 |
| Emmaus Life Sciences (EMMA) |
United States |
$0.064B |
0.00 |
| ARIDIS PHARMACT (ARDS) |
United States |
$0.063B |
0.00 |
| Stealth BioTherapeutics (MITO) |
Cayman Islands |
$0.062B |
0.00 |
| ATyr Pharma (LIFE) |
United States |
$0.060B |
0.00 |
| Organovo Holdings (ONVO) |
United States |
$0.060B |
0.00 |
| Genetic Technologies (GENE) |
Australia |
$0.058B |
0.00 |
| ZIVO Bioscience (ZIVO) |
United States |
$0.057B |
0.00 |
| Aerpio Pharmaceuticals (ARPO) |
United States |
$0.057B |
0.00 |
| Advaxis (ADXS) |
United States |
$0.056B |
0.00 |
| Alimera Sciences (ALIM) |
United States |
$0.056B |
0.00 |
| Windtree Therapeutics (WINT) |
United States |
$0.056B |
0.00 |
| AnPac Bio-Medical Science (ANPC) |
China |
$0.056B |
0.00 |
| AEterna Zentaris (AEZS) |
United States |
$0.055B |
0.00 |
| Pulmatrix (PULM) |
United States |
$0.055B |
0.00 |
| Appili Therapeutics (APLIF) |
Canada |
$0.052B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.052B |
0.00 |
| Enveric Biosciences (ENVB) |
United States |
$0.052B |
0.00 |
| Happiness Biotech Group (HAPP) |
China |
$0.048B |
0.00 |
| Idera Pharmaceuticals (IDRA) |
United States |
$0.046B |
0.00 |
| Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.046B |
0.00 |
| Yumanity Therapeutics (YMTX) |
United States |
$0.046B |
0.00 |
| Cyclo Therapeutics (CYTH) |
United States |
$0.044B |
0.00 |
| Clene (CLNN) |
United States |
$0.040B |
0.00 |
| Vyant Bio (VYNT) |
United States |
$0.040B |
0.00 |
| Acorda Therapeutics (ACOR) |
United States |
$0.040B |
0.59 |
| Invo BioScience (INVO) |
United States |
$0.039B |
0.00 |
| Sonnet BioTherapeutics Holdings (SONN) |
United States |
$0.037B |
0.00 |
| Vallon Pharmaceuticals (VLON) |
United States |
$0.031B |
0.00 |
| IMMURON (IMRN) |
Australia |
$0.031B |
0.00 |
| GeoVax Labs (GOVX) |
United States |
$0.030B |
0.00 |
| ThermoGenesis Holdings (THMO) |
United States |
$0.029B |
0.00 |
| Prana Biotechnology (ATHE) |
Australia |
$0.029B |
0.00 |
| Lexaria Bioscience (LEXX) |
Canada |
$0.025B |
0.00 |
| Seneca Biopharma (SNCA) |
United States |
$0.024B |
0.00 |
| Titan Pharmaceuticals (TTNP) |
United States |
$0.023B |
0.00 |
| Benitec Biopharma (BNTC) |
United States |
$0.022B |
0.00 |
| China Biologic Products (CBPO) |
China |
$0.000B |
29.28 |
| Entera Bio (ENTX) |
Israel |
$0.000B |
0.00 |
| ImmunityBio (IBRX) |
United States |
$0.000B |
0.00 |
| Immatics (IMTX) |
United States |
$0.000B |
0.00 |
| Viridian Therapeutics (VRDN) |
United States |
$0.000B |
0.00 |
